Skip to main content

Table 3 Significance of the prognostic predictors in the univariate survival analysis

From: Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy

Parameters No. of patients Survival rate (%) p
   2-yr 4-yr  
Age (years)     0.795
   >60 554 68 39  
   ≤ 60 232 70 37  
Gender     0.713
   Male 576 69 42  
   Female 210 71 29  
HBsAg     0.589
   Positive 393 68 42  
   Negative 393 70 34  
Ascites     <0.001
   Yes 101 50 11  
   No 685 72 42  
Performance status     <0.001
   ECOG 0 590 75 45  
   ECOG 1 or higher 196 51 10  
Vascular invasion     <0.001
   Yes 87 35 22  
   No 699 72 41  
AFP (ng/mL)     <0.001
   >100 253 58 33  
   <100 533 74 42  
MELD score     0.04
   >10 234 62 36  
   <10 552 72 40  
CTP score     <0.001
   5 451 75 50  
   6 or higher 335 60 25  
ALT (IU/L)     0.934
   >40 499 70 38  
   ≤ 40 287 67 40  
AST (IU/L)     0.001
   >40 551 65 31  
   ≤ 40 235 77 52  
Total tumor volume (cm3)     <0.001
   <10 297 80 48  
   10-50 226 74 47  
   50-200 121 56 25  
   200-500 57 54 -  
   >500 85 34 10